| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Canaan VIII LP last filed a Form 4 in August 2019, as Director at CDLX.
Canaan VIII LP has 8 Form 4 filings on record from February 2018 to August 2019, all as Director at Cardlytics (CDLX), 2018–2019.
The 11 reported transactions were 5 other transactions, 3 open-market sales, 1 option exercise and 1 option or other derivative award, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $6.0M.
The only open-market sale was 187,683 shares of CDLX at an average $31.92 on August 12, 2019, about $6.0M.
Shares as reported in the last Form 4 for each company; the most recent is from August 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2019 | CDLX Cardlytics, Inc. | Director | Sell | 187,683 | $31.92 | $5,991,632.88 | -100% |